Cholesterol Absorption and Metabolism and LDL Kinetics in Healthy Men With Different Apoprotein E Phenotypes and Apoprotein BXbaI and LDL ReceptorPvuII Genotypes
- 1 February 1995
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 15 (2) , 208-213
- https://doi.org/10.1161/01.atv.15.2.208
Abstract
Apoprotein (apo) E, apoB Xba I, and LDL receptor gene Pvu II polymorphisms are associated with LDL cholesterol level, but little is known about cholesterol and LDL metabolism in subjects with the latter two genetic polymorphisms alone or in combination with different apoE phenotypes. We studied cholesterol absorption efficiency, cholesterol and bile acid synthesis, and LDL apoB kinetics in 52 healthy men and related the metabolic results to the apoB Xba I and LDL receptor Pvu II restriction fragment length polymorphism (RFLP) and apoE phenotypes. New findings were as follows. ApoB Xba I polymorphism was not associated with the metabolic variables of cholesterol, but LDL receptor Pvu II RFLP was associated with fractional catabolic rate for LDL apoB, cholesterol absorption, and cholesterol and bile acid synthesis. ApoE polymorphism exerted the most powerful effect on the LDL cholesterol concentration, so that the apoE2 subjects had the lowest LDL cholesterol and apoB levels and cholesterol absorption, and the highest fractional catabolic rate and bile acid and cholesterol synthesis compared with the apoE3 or especially apoE4 phenotypes in different genetic combinations. In multiple stepwise regression analysis with LDL cholesterol as the dependent and the genetic and metabolic parameters as the independent variables, 47.0% (n=35, P<.001) of the variability of LDL cholesterol was explained by the apoE polymorphism, 7.1% (P<.05) by the LDL receptor Pvu II RFLP, and 11.3% (P<.01) by bile acid synthesis, while the contribution of the apoB Xba I RFLP was nonsignificant. In conclusion, LDL cholesterol level was lowest in subjects with the ε2 allele, irrespective of their Xba I or Pvu II genotypes; this was due to lower cholesterol absorption efficiency, more effective cholesterol and bile acid synthesis, and more efficient fractional catabolic rate in carriers of the ε2 allele when compared with the other genetic subgroups.Keywords
This publication has 39 references indexed in Scilit:
- Apolipoprotein B gene polymorphisms, lipoproteins and coronary atherosclerosis: A study of young myocardial infarction survivors and healthy population-based individualsAtherosclerosis, 1992
- Association of DNA polymorphism at the apolipoprotein B gene locus with coronary heart disease and serum very low density lipoprotein levels.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
- Interaction between low density lipoprotein receptor (LDLR) and apolipoprotein E (apoE) alleles contributes to normal variation in lipid levelClinical Genetics, 1989
- Normal DNA polymorphism at the low density lipoprotein receptor (LDLR) locus associated with serum cholesterol levelClinical Genetics, 1988
- Identification of a deletion in the LDL receptor gene A Finnish type of mutationFEBS Letters, 1988
- DNA polymorphisms of the gene for apolipoprotein B in patients with peripheral arterial diseaseAtherosclerosis, 1988
- Apolipoprotein B gene variants are involved in the determination of serum cholesterol levels: a study in normo- and hypelipidaemic individualsAtherosclerosis, 1987
- Apolipoprotein B–Gene DNA Polymorphisms Associated with Myocardial InfarctionNew England Journal of Medicine, 1986
- DNA polymorphism at the apolipoprotein B locus is associated with lipoprotein levelClinical Genetics, 1986
- The metabolism of very low density lipoprotein proteins I. Preliminary in vitro and in vivo observationsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1972